Entity Common Stock, Shares Outstanding of Nurix Therapeutics, Inc. from 07 Oct 2020 to 23 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nurix Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 07 Oct 2020 to 23 Jan 2026.
  • Nurix Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Jan 2026 was 102,843,012, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 102,843,012 +26,956,195 +36% 23 Jan 2026 10-K 28 Jan 2026 2025 FY
Q3 2025 76,883,436 +6,047,154 +8.5% 30 Sep 2025 10-Q 09 Oct 2025 2025 Q3
Q2 2025 76,449,355 +12,037,485 +19% 30 Jun 2025 10-Q 09 Jul 2025 2025 Q2
Q1 2025 76,235,594 +27,084,800 +55% 01 Apr 2025 10-Q 08 Apr 2025 2025 Q1
Q4 2024 75,886,817 +26,992,733 +55% 24 Jan 2025 10-K 28 Jan 2025 2024 FY
Q3 2024 70,836,282 +22,332,514 +46% 10 Oct 2024 10-Q 11 Oct 2024 2024 Q3
Q2 2024 64,411,870 +16,211,799 +34% 01 Jul 2024 10-Q 11 Jul 2024 2024 Q2
Q1 2024 49,150,794 +1,705,440 +3.6% 01 Apr 2024 10-Q 10 Apr 2024 2024 Q1
Q4 2023 48,894,084 +1,620,986 +3.4% 05 Feb 2024 10-K 15 Feb 2024 2023 FY
Q3 2023 48,503,768 +1,355,987 +2.9% 02 Oct 2023 10-Q 12 Oct 2023 2023 Q3
Q2 2023 48,200,071 +1,158,196 +2.5% 30 Jun 2023 10-Q 13 Jul 2023 2023 Q2
Q1 2023 47,445,354 +2,495,160 +5.6% 31 Mar 2023 10-Q 13 Apr 2023 2023 Q1
Q4 2022 47,273,098 +2,535,330 +5.7% 31 Jan 2023 10-K 09 Feb 2023 2022 FY
Q3 2022 47,147,781 +2,535,134 +5.7% 30 Sep 2022 10-Q 06 Oct 2022 2022 Q3
Q2 2022 47,041,875 +2,615,019 +5.9% 30 Jun 2022 10-Q 07 Jul 2022 2022 Q2
Q1 2022 44,950,194 +602,753 +1.4% 31 Mar 2022 10-Q 08 Apr 2022 2022 Q1
Q4 2021 44,737,768 +5,830,545 +15% 21 Jan 2022 10-K 28 Jan 2022 2021 FY
Q3 2021 44,612,647 +5,757,208 +15% 08 Oct 2021 10-Q 14 Oct 2021 2021 Q3
Q2 2021 44,426,856 09 Jul 2021 10-Q 13 Jul 2021 2021 Q2
Q1 2021 44,347,441 09 Apr 2021 10-Q 13 Apr 2021 2021 Q1
Q4 2020 38,907,223 11 Feb 2021 10-K 16 Feb 2021 2020 FY
Q3 2020 38,855,439 07 Oct 2020 10-Q 14 Oct 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.